Immunosuppressive agents in adult kidney transplantation in the National Health Service: a model-based economic evaluation

Abstract

A regimen comprising induction with basiliximab, followed by maintenance therapy with immediate-release tacrolimus and mycophenolate mofetil, is likely to be effective for uncomplicated adult kidney transplant patients and a cost-effective use of NHS resources.